{"nct_id":"NCT04816214","title":"Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy","status":"TERMINATED","status_verified_date":"2024-03","start_date":"2021-09-22","start_date_type":"ACTUAL","primary_completion_date":"2022-12-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}